CochlearCHEOF 62 EV-to-FCF is 49.32 as of Jul. 02, 2026, which is 14% below its 10-year median of 57.35. GuruFocus rates CHEOF with a GF Score™ of 62/100 and a GF Value™ of $219.85 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Cochlear ranks worse than 75.3% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cochlear's Enterprise Value is $5,378 Mil.
Cochlear's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $109 Mil. Therefore, Cochlear's EV-to-FCF for today is 49.32.
The historical rank and industry rank for Cochlear's EV-to-FCF or its related term are showing as below:
CHEOF'
s EV-to-FCF Range Over the Past 10 Years
Min: -50.68 Med: 57.35 Max: 151.34
Current: 50.68
During the past 13 years, the highest EV-to-FCF of Cochlear was 151.34. The lowest was -50.68. And the median was 57.35.
CHEOF's EV-to-FCF is ranked worse than 75.3% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 22.52
vs CHEOF: 50.68
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cochlear's share price for today is $81.42.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cochlear's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $3.468.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cochlear EV-to-FCF Related Terms
Cochlear EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Cochlear's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cochlear's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cochlear EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cochlear's EV-to-FCF falls into.
Cochlear's current Enterprise Value is $5,378 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cochlear's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $109 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cochlear (CHEOF) has a EV-to-FCF of 49.32 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cochlear and its competitors. This is 14% below median its historical median of 57.35. According to the industry distribution chart, Cochlear ranks #314 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 75.3%.
Is Cochlear's EV-to-FCF too high?
Cochlear's current EV-to-FCF of 49.32 is 14% below median its 10-year median of 57.35. The Medical Devices & Instruments industry median EV-to-FCF is 22.52. Cochlear's value of 49.32 is 119% above this industry median. Based on the distribution chart, Cochlear ranks #314 out of 417 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cochlear has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cochlear's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cochlear ranks #314 out of 417 companies for EV-to-FCF. This places Cochlear in the lower half of its industry. The industry median EV-to-FCF is 22.52. Cochlear's value of 49.32 is 119% above this benchmark. While the company's 10-year median is 57.35 vs. the industry median of 22.52, Cochlear has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.52, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cochlear's current EV-to-FCF of 49.32 is 119% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cochlear and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cochlear's current EV-to-FCF is 49.32, which is 14% below median its own 10-year median of 57.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Based on GuruFocus' analysis, Cochlear (CHEOF) is currently considered Significantly Undervalued. The stock's GF Value™ is $219.85, compared to a current price of $81.42 — trading 63% below its estimated fair value. The current EV-to-FCF is 49.32, which is 14% below median its 10-year median of 57.35 and 119% above the Medical Devices & Instruments industry median of 22.52. Cochlear's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cochlear (CHEOF), the current EV-to-FCF is 49.32 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cochlear (CHEOF) Overvalued in 2026?
Based on GuruFocus' analysis, Cochlear stock appears to be undervalued.
The current stock price of $81.42 is trading 63% below its estimated GF Value™ of $219.85.
GuruFocus considers Cochlear to be Significantly Undervalued.
Key valuation signals for CHEOF:
EV-to-FCF: 49.32 (14% below median its 10-year median of 57.35)
GF Value™: $219.85 vs. price of $81.42 (63% below fair value)
Industry Position: 119% above the Medical Devices & Instruments median (#314 of 417)
No single metric tells the full story. See the CHEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
62GF Score
Get the complete analysis for CHEOF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHEOF has been successfully added to your 
